2022 Women's Venture Competition
The AIM-HI Accelerator Fund congratulates our 2022 Women’s Venture Competition top finalists, determined by a panel of blue-ribbon judging committee consisting of world-class life sciences industry professionals, business leaders, investors and entrepreneurs:
• First Place with distinction: Johanna Webb, President & CEO of RiverWalk Therapeutics
• Second Place: Revital Mandil-Levin, Ph.D., CEO & Co-Founder of Nanocarry Therapeutics
• Third Place: Rosa Hwang, M.D., Co-Founder of Stellanova Therapeutics
We also hosted a “People’s Choice for Best Pitch” voting campaign, asking the public to select their favorite 1-min pitch video, to spread the word about these innovative oncology startups led by women entrepreneurs. The People’s Choice winner this year went to Zeenia Kaul, Ph.D., Co-Founder, CEO & CSO of ReHava BioSciences.
Ready to do more? DONATE NOW and help us double the impact for women scientist-entrepreneurs who are creating life-saving oncology innovations!
First Place with Distinction

Johanna Webb
President

Second Place
Third Place
People’s Choice for Best Pitch
Semi-Finalists
The AIM-HI Accelerator Fund congratulates our 10 women scientist-entrepreneur semi-finalists and their companies of the 2021 Women’s Venture Competition. The winning company of 2021 Women’s Venture Competition will receive a total of $1 million in investment from AIM-HI and co-investors, subject to due diligence and negotiation. which will serve as early seed money for proof of concept and proof of value on the path to clinical trials and, eventually, to new effective therapeutics that could save patients’ lives.
In addition, the AIM-HI Women’s Venture Competition is looking to name one of our semi-finalists as the People’s Choice Award for Best Pitch. Who will it be? We can’t all be on the official Judging Committee for the Women’s Venture Competition … but we can ALL Cast our Vote!
Ready to do more? DONATE NOW and help us double the impact for women scientist-entrepreneurs who are creating life-saving oncology innovations!